Risk of uveitis in SpA is changing

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2024-10-31 DOI:10.1038/s41584-024-01185-7

Sarah Onuora

引用次数: 0

Abstract

Findings from an observational study suggest that the frequency of uveitis in patients with spondyloarthritis has declined since the introduction of biologic DMARDs.

查看原文本刊更多论文

SpA 葡萄膜炎的风险正在发生变化

一项观察性研究结果表明，自生物 DMARDs 问世以来，脊柱关节炎患者发生葡萄膜炎的频率有所下降。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.